Thyroid-associated Ophthalmopathy
📧 Sign up to get email alerts when something new happens for Thyroid-associated Ophthalmopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: MHB018A Treatment in Patients With Active Thyroid Eye Disease [Phase 3]
A Phase 3 clinical trial evaluating MHB018A for active thyroid-associated ophthalmopathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of sequential hormone therapy followed by Tetuzumab in patients with moderate…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. [Phase 4]
Phase 4 clinical trial update evaluating sequential hormone therapy followed by IBI311 therapy in active moderate to severe thyroid-associat…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
This clinical trial update describes the development of a precise diagnosis and treatment system for thyroid-associated ophthalmopathy and i…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy
This clinical trial update reports the establishment of multimodal-multiparametric progressive prediction models for Thyroid-associated opht…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
A clinical study sponsored by Shanghai Changzheng Hospital is establishing multiparametric prediction models for moderate to severe Thyroid-…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy [Phase 4]
Phase 4 clinical trial evaluating the combined use of tocilizumab and flupentixol-melitracen for Thyroid-Associated Ophthalmopathy, currentl…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Treatment of Graves´ophthalmopathy with Simvastatin (GO-S) [Phase 3]
A Phase 3 clinical trial evaluating simvastatin for Graves' ophthalmopathy is currently recruiting.
-
CLINICAL_TRIALS research · 2017-04-18Clinical Trial Update: Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial [Phase 4]
This is a Phase 4 multicenter randomized trial evaluating a novel classification system in intravenous glucocorticoid therapy for Thyroid-as…
-
CLINICAL_TRIALS research · 2013-12-10Clinical Trial Update: Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy [Phase 2, Phase 3]
A clinical trial update about a Phase 2/Phase 3 study comparing prednisone to doxycycline for Graves' orbitopathy (thyroid-associated ophtha…